XML 32 R17.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes:
12 Months Ended
Dec. 31, 2016
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
Income Taxes
 

Income from continuing operations before taxes consisted of the following (in thousands): 

 
 
Year Ended December 31,
 
 
2016
 
2015
 
2014
United States
 
$
80,714

 
$
74,288

 
$
33,508

Foreign
 
4,450

 
(4,589
)
 
6,284

 
 
$
85,164

 
$
69,699

 
$
39,792



The provision (benefit) for income taxes consisted of the following (in thousands):
 
 
Year Ended December 31,
 
 
2016
 
2015
 
2014
Current:
 
 

 
 

 
 

Federal
 
$
21,123

 
$
18,601

 
$
13,860

State
 
2,347

 
745

 
(1,305
)
Foreign
 
1,118

 
1,426

 
2,100

 
 
24,588

 
20,772

 
14,655

Deferred:
 
 

 
 

 
 

Federal
 
$
(2,045
)
 
$
4,524

 
$
(2,325
)
State
 
(767
)
 
(960
)
 
988

Foreign
 
304

 
378

 
139

 
 
(2,508
)
 
3,942

 
(1,198
)
 
 
$
22,080

 
$
24,714

 
$
13,457


 
Current income taxes payable were reduced from the amounts in the above table by $9.3 million and $5.7 million in 2015 and 2014, respectively, equal to the direct tax benefit that we receive upon exercise of stock options by employees and directors. We have accrued for tax contingencies for potential tax assessments, and in 2016 we recognized a $0.2 million net increase, most of which related to various federal and state tax reserves.
 
A reconciliation of the provision for income taxes at the statutory rate to our effective tax rate is as follows (dollars in thousands):
 
 
Year Ended December 31,
 
 
2016
 
2015
 
2014
 
 
Amount
 
Percent
 
Amount
 
Percent
 
Amount
 
Percent
Federal tax at the expected statutory rate
 
$
29,807

 
35.0
 %
 
$
24,395

 
35.0
 %
 
$
13,927

 
35.0
 %
State income tax, net of federal effect
 
1,795

 
2.1
 %
 
2,661

 
3.9
 %
 
981

 
2.5
 %
Tax credits
 
(1,014
)
 
(1.2
)%
 
(5,861
)
 
(8.4
)%
 
(1,591
)
 
(4.0
)%
Domestic production activities/other
 
(653
)
 
(0.8
)%
 
107

 
0.1
 %
 
101

 
0.2
 %
Foreign income tax
 
(135
)
 
(0.1
)%
 
3,412

 
4.9
 %
 
39

 
0.1
 %
Stock compensation - ASU 2016-09
 
(7,720
)
 
(9.1
)%
 

 
 %
 

 
 %
 
 
$
22,080

 
25.9
 %
 
$
24,714

 
35.5
 %
 
$
13,457

 
33.8
 %

 
Tax credits in 2016, 2015 and 2014 consist principally of research and developmental tax credits.  Prior to the adoption of ASU 2016-09 in 2016, the indirect effect of non-statutory stock options exercised on research and development tax credits and other tax credits were recorded as reductions of the effective tax provision.

The components of our deferred income tax provision are as follows (in thousands): 



 
 
Year Ended December 31,
 
 
2016
 
2015
 
2014
Allowance for doubtful accounts
 
$

 
$

 
$
4

Inventory reserves
 
(162
)
 
284

 
(488
)
Accruals
 
(2,599
)
 
(2,977
)
 
(1,326
)
State income taxes
 
61

 
502

 
(4
)
Acquired future tax deductions
 
1,520

 
3,139

 
96

Depreciation and amortization
 
(2,544
)
 
1,080

 
(780
)
Net operating loss
 
(2,256
)
 
195

 
62

Tax credits
 
(873
)
 
(635
)
 
1,238

Valuation allowance
 
4,345

 
2,354

 

 
 
$
(2,508
)
 
$
3,942

 
$
(1,198
)


The components of our deferred income tax assets (liabilities) are as follows (in thousands):

 
 
December 31,
 
 
2016
 
2015
Deferred tax asset:
 
 

 
 

State income taxes
 
$
(1,708
)
 
$
(1,647
)
Foreign
 
1,223

 
3,881

Accruals/other
 
857

 
1,432

Depreciation and amortization
 
(10,027
)
 
(11,735
)
Acquired future tax deductions
 
6,473

 
5,778

Stock-based compensation
 
11,089

 
8,864

Foreign currency translation adjustments
 
5,175

 
5,360

Tax credits state
 
6,764

 
5,887

Inventory reserves
 
1,938

 
1,633

Allowance for doubtful accounts
 
151

 

Valuation allowance
 

 
(2,354
)
 
 
$
21,935

 
17,099

Deferred tax liability:
 
 

 
 

Foreign
 
$
1,370

 
$
1,372

 
 
$
1,370

 
$
1,372


 
Acquired future tax deductions are the tax benefits included in our consolidated income tax returns originating in Bio-Plexus, Inc., an entity purchased in 2002, prior to when we acquired the entity, and those originating from EXC acquired in 2015. They consist of: (a) the net tax benefit of items expensed for financial statement purposes but capitalized and amortized for tax purposes, (b) the tax benefited portion of Bio-Plexus’s federal net operating loss ("NOL") carry-forward of $1.2 million which will be realized in approximately equal amounts over the next 7 years, and (c) the tax benefited portion of EXC's NOL carryforward of $4.1 million which is expected to be realized in approximately 4 years, and will expire in 17 years. Under Section 382 of the Internal Revenue Code, certain ownership changes limit the utilization of the NOL carry-forwards, and the amount of federal NOL carry-forwards recorded is the net federal benefit available.

Foreign currency translation adjustments, and related tax effects, are an element of “other comprehensive income” and are not included in net income.

    
Our estimate of undistributed earnings of our foreign subsidiaries for which no federal or state liability has been recorded cumulatively was $10.8 million at December 31, 2016 and $17.8 million at December 31, 2015.  These undistributed earnings are considered to be indefinitely reinvested. However, if unanticipated distribution of those earnings were to occur in the form of dividends or otherwise, some portion of the distribution would be subject to both foreign withholding taxes and U.S. income taxes.  In the event that our position in this regard changes, determining the potential amount of unrecognized deferred federal and state income tax liability and foreign withholding taxes is not practicable because of the complexities associated with its hypothetical calculation. However, unrecognized foreign tax credits would be available to reduce some portion of the federal liability.

We are subject to taxation in the United States and various states and foreign jurisdictions. Our United States federal income tax returns for tax years 2013 and forward are subject to examination by the Internal Revenue Service. Our principal state income tax returns for tax years 2012 and forward are subject to examination by the state tax authorities. The total gross amount of unrecognized tax benefits as of December 31, 2016 was $2.0 million which, if recognized, would impact the effective tax rate.
 
The following table summarizes our cumulative gross unrecognized tax benefits (in thousands): 
 
 
Year Ended December 31,
 
 
2016
 
2015
 
2014
Beginning balance
 
$
1,772

 
$
4,115

 
$
5,544

Increases to prior year tax positions
 
77

 
25

 
217

Increases to current year tax positions
 
345

 
345

 
661

Decreases to prior year tax positions
 
(46
)
 
(2,399
)
 

Decrease related to settlements
 

 
(314
)
 
(2,113
)
Decrease related to lapse of statute of limitations
 
(148
)
 

 
(194
)
Ending balance
 
$
2,000

 
$
1,772

 
$
4,115